| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6596260 | GLAXOSMITHKLINE | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Aug, 2014
(9 years ago) | |
|
US6596260 (Pediatric) | GLAXOSMITHKLINE | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Feb, 2015
(9 years ago) | |
| US6558651 | GLAXOSMITHKLINE | Aerosols containing annealed particulate salbutamol and tetrafluoroethane |
Dec, 2016
(7 years ago) | |
|
US6558651 (Pediatric) | GLAXOSMITHKLINE | Aerosols containing annealed particulate salbutamol and tetrafluoroethane |
Jun, 2017
(6 years ago) | |
| US6315173 | GLAXOSMITHKLINE | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6170717 | GLAXOSMITHKLINE | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6510969 | GLAXOSMITHKLINE | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6966467 | GLAXOSMITHKLINE | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6161724 | GLAXOSMITHKLINE | Indicating device |
Jan, 2018
(6 years ago) | |
| US6997349 | GLAXOSMITHKLINE | Indicating device |
Jan, 2018
(6 years ago) | |
| US6435372 | GLAXOSMITHKLINE | Delivery system for a medicament and method for the assembly thereof |
Jan, 2018
(6 years ago) | |
| US6938796 | GLAXOSMITHKLINE | Indicating device |
Jan, 2018
(6 years ago) | |
| US7143908 | GLAXOSMITHKLINE | Indicating device |
Jan, 2018
(6 years ago) | |
| US7107986 | GLAXOSMITHKLINE | Dispenser with doses' counter |
Jun, 2018
(5 years ago) | |
| US6431168 | GLAXOSMITHKLINE | Dispenser with doses′ counter |
Jun, 2018
(5 years ago) | |
|
US6966467 (Pediatric) | GLAXOSMITHKLINE | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6315173 (Pediatric) | GLAXOSMITHKLINE | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6170717 (Pediatric) | GLAXOSMITHKLINE | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6510969 (Pediatric) | GLAXOSMITHKLINE | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6435372 (Pediatric) | GLAXOSMITHKLINE | Delivery system for a medicament and method for the assembly thereof |
Jul, 2018
(5 years ago) | |
|
US6161724 (Pediatric) | GLAXOSMITHKLINE | Indicating device |
Jul, 2018
(5 years ago) | |
|
US7143908 (Pediatric) | GLAXOSMITHKLINE | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6938796 (Pediatric) | GLAXOSMITHKLINE | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6997349 (Pediatric) | GLAXOSMITHKLINE | Indicating device |
Jul, 2018
(5 years ago) | |
| US7350676 | GLAXOSMITHKLINE | Valve for aerosol container |
Aug, 2018
(5 years ago) | |
|
US7107986 (Pediatric) | GLAXOSMITHKLINE | Dispenser with doses' counter |
Dec, 2018
(5 years ago) | |
|
US6431168 (Pediatric) | GLAXOSMITHKLINE | Dispenser with doses′ counter |
Dec, 2018
(5 years ago) | |
|
US7350676 (Pediatric) | GLAXOSMITHKLINE | Valve for aerosol container |
Feb, 2019
(5 years ago) | |
| US9861771 | GLAXOSMITHKLINE | Device housing for an aerosol container |
Oct, 2020
(3 years ago) | |
| US6743413 | GLAXOSMITHKLINE | Suspension aerosol formulations |
Jun, 2021
(2 years ago) | |
|
US6743413 (Pediatric) | GLAXOSMITHKLINE | Suspension aerosol formulations |
Dec, 2021
(2 years ago) | |
| US7832351 | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Jun, 2023
(10 months ago) | |
|
US7832351 (Pediatric) | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Dec, 2023
(4 months ago) | |
| US7500444 | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Feb, 2026
(1 year, 9 months from now) | |
|
US7500444 (Pediatric) | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Aug, 2026
(2 years from now) | |
Ventolin Hfa is owned by Glaxosmithkline.
Ventolin Hfa contains Albuterol Sulfate.
Ventolin Hfa has a total of 35 drug patents out of which 33 drug patents have expired.
Expired drug patents of Ventolin Hfa are:
- US6596260
- US6596260*PED
- US6558651
- US6558651*PED
- US6315173
- US6170717
- US6510969
- US6966467
- US6161724
- US6997349
- US6435372
- US6938796
- US7143908
- US7107986
- US6431168
- US6966467*PED
- US6315173*PED
- US6170717*PED
- US6510969*PED
- US6435372*PED
- US6161724*PED
- US7143908*PED
- US6938796*PED
- US6997349*PED
- US7350676
- US7107986*PED
- US6431168*PED
- US7350676*PED
- US9861771
- US6743413
- US6743413*PED
- US7832351
- US7832351*PED
Ventolin Hfa was authorised for market use on 19 April, 2001.
Ventolin Hfa is available in aerosol, metered;inhalation dosage forms.
Ventolin Hfa can be used as the treatment or prevention of bronchospasm in adults and children 4 years of age and older with reversible obstructive airways disease and the prevention of exercised-induced bronchospasm in patients 4 years of age and older.
The generics of Ventolin Hfa are possible to be released after 26 August, 2026.
Drugs and Companies using ALBUTEROL SULFATE ingredient
Market Authorisation Date: 19 April, 2001
Treatment: The treatment or prevention of bronchospasm in adults and children 4 years of age and older with reversible obstructive airways disease and the prevention of exercised-induced bronchospasm in patients...
Dosage: AEROSOL, METERED;INHALATION
VENTOLIN HFA family patents
